311 related articles for article (PubMed ID: 34358488)
1. Host Genetic Determinants Associated With Helicobacter pylori Eradication Treatment Failure: A Systematic Review and Meta-analysis.
Shah SC; Tepler A; Chung CP; Suarez G; Peek RM; Hung A; Roumie C; Narula N
Gastroenterology; 2021 Nov; 161(5):1443-1459. PubMed ID: 34358488
[TBL] [Abstract][Full Text] [Related]
2. Effects of Genetic Polymorphisms of Cytochrome P450 Enzymes and MDR1 Transporter on Pantoprazole Metabolism and Helicobacter pylori Eradication.
Karaca RO; Kalkisim S; Altinbas A; Kilincalp S; Yuksel I; Goktas MT; Yasar U; Bozkurt A; Babaoglu MO
Basic Clin Pharmacol Toxicol; 2017 Feb; 120(2):199-206. PubMed ID: 27611887
[TBL] [Abstract][Full Text] [Related]
3. Effects of CYP2C19, MDR1, and interleukin 1-B gene variants on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxicillin, and metronidazole.
Gawrońska-Szklarz B; Siuda A; Kurzawski M; Bielicki D; Marlicz W; Droździk M
Eur J Clin Pharmacol; 2010 Jul; 66(7):681-7. PubMed ID: 20376628
[TBL] [Abstract][Full Text] [Related]
4. Clarithromycin resistance and female gender affect Helicobacter pylori eradication failure in chronic gastritis.
Chang YW; Ko WJ; Oh CH; Park YM; Oh SJ; Moon JR; Cho JH; Kim JW; Jang JY
Korean J Intern Med; 2019 Sep; 34(5):1022-1029. PubMed ID: 29898576
[TBL] [Abstract][Full Text] [Related]
5. Effects of CYP2C19 and MDR1 genotype on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxycillin and clarithromycin.
Oh JH; Dong MS; Choi MG; Yoo HW; Lee SB; Park YI; Chung IS
J Gastroenterol Hepatol; 2009 Feb; 24(2):294-8. PubMed ID: 18823430
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in the host CYP2C19 gene and antibiotic-resistance attributes of Helicobacter pylori isolates influence the outcome of triple therapy.
Ram M R; Teh X; Rajakumar T; Goh KL; Leow AHR; Poh BH; Mariappan V; Shankar EM; Loke MF; Vadivelu J
J Antimicrob Chemother; 2019 Jan; 74(1):11-16. PubMed ID: 30403784
[TBL] [Abstract][Full Text] [Related]
7. Influence of inflammatory cytokine polymorphisms on eradication rates of Helicobacter pylori.
Sugimoto M; Furuta T; Yamaoka Y
J Gastroenterol Hepatol; 2009 Nov; 24(11):1725-32. PubMed ID: 20136959
[TBL] [Abstract][Full Text] [Related]
8. CYP2C19 polymorphism influences Helicobacter pylori eradication.
Kuo CH; Lu CY; Shih HY; Liu CJ; Wu MC; Hu HM; Hsu WH; Yu FJ; Wu DC; Kuo FC
World J Gastroenterol; 2014 Nov; 20(43):16029-36. PubMed ID: 25473155
[TBL] [Abstract][Full Text] [Related]
9. Gastric Juice-Based Real-Time PCR for Tailored
Peng X; Song Z; He L; Lin S; Gong Y; Sun L; Zhao F; Gu Y; You Y; Zhou L; Zhang J
Int J Med Sci; 2017; 14(6):595-601. PubMed ID: 28638276
[TBL] [Abstract][Full Text] [Related]
10. First-line eradication for Helicobacter pylori-positive gastritis by esomeprazole-based triple therapy is influenced by CYP2C19 genotype.
Saito Y; Serizawa H; Kato Y; Nakano M; Nakamura M; Saito H; Suzuki H; Kanai T
World J Gastroenterol; 2015 Dec; 21(48):13548-54. PubMed ID: 26730167
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of H. pylori eradication depending on genetic polymorphism of CYP2C19, MDR1 and IL-1β].
Bakulina NV; Maev IV; Savilova IV; Bakulin IG; Il'chishina TA; Zagorodnikova KA; Murzina AA; Andreev DN
Ter Arkh; 2019 Aug; 91(8):34-40. PubMed ID: 32598752
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic resistance and CYP2C19 polymorphisms affect the efficacy of concomitant therapies for Helicobacter pylori infection: an open-label, randomized, single-centre clinical trial.
Hong J; Shu X; Liu D; Zhu Y; Xie C; Xie Y; Zhang K; Wang A; Xiong H; Zeng H; Yu H; Ma J; Chen Y; Zhu X; Lu N
J Antimicrob Chemother; 2016 Aug; 71(8):2280-5. PubMed ID: 27107097
[TBL] [Abstract][Full Text] [Related]
13. Factors affecting first-line triple therapy of Helicobacter pylori including CYP2C19 genotype and antibiotic resistance.
Lee JY; Kim N; Kim MS; Choi YJ; Lee JW; Yoon H; Shin CM; Park YS; Lee DH; Jung HC
Dig Dis Sci; 2014 Jun; 59(6):1235-43. PubMed ID: 24599773
[TBL] [Abstract][Full Text] [Related]
14. Application of Visual Gene Clip-Based Tailored Therapy for the Eradication of
Yang L; Zou A; Wu H; Guo H; Zhang F; Zou B; Wang J
Biomed Res Int; 2021; 2021():6150628. PubMed ID: 33937401
[TBL] [Abstract][Full Text] [Related]
15. Effect of IL-1 Polymorphisms, CYP2C19 Genotype and Antibiotic Resistance on Helicobacter pylori Eradication Comparing Between 10-day Sequential Therapy and 14-day Standard Triple Therapy with Four-Times-Daily-Dosing of Amoxicillin in Thailand: a Prospective Randomized Study.
Phiphatpatthamaamphan K; Vilaichone RK; Siramolpiwat S; Tangaroonsanti A; Chonprasertsuk S; Bhanthumkomol P; Pornthisarn B; Mahachai V
Asian Pac J Cancer Prev; 2016; 17(4):1903-7. PubMed ID: 27221874
[TBL] [Abstract][Full Text] [Related]
16. Microarray-Based Detection and Clinical Evaluation for
Song Y; Dou F; Zhou Z; Yang N; Zhong J; Pan J; Liu Q; Zhang J; Wang S
Biomed Res Int; 2018; 2018():2684836. PubMed ID: 30276203
[No Abstract] [Full Text] [Related]
17. Polymorphism of interleukin-1beta affects the eradication rates of Helicobacter pylori by triple therapy.
Furuta T; Shirai N; Xiao F; El-Omar EM; Rabkin CS; Sugimura H; Ishizaki T; Ohashi K
Clin Gastroenterol Hepatol; 2004 Jan; 2(1):22-30. PubMed ID: 15017629
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of tailored Helicobacter pylori eradication therapy based on antibiotic susceptibility and CYP2C19 genotype.
Sugimoto M; Furuta T
World J Gastroenterol; 2014 Jun; 20(21):6400-11. PubMed ID: 24914361
[TBL] [Abstract][Full Text] [Related]
19. CYP2C19 Genotype, CagA Genotype and Antibiotic Resistant Strain of Helicobacter pylori Infection.
Auttajaroon J; Chotivitayatarakorn P; Yamaoka Y; Vilaichone RK
Asian Pac J Cancer Prev; 2019 Apr; 20(4):1243-1247. PubMed ID: 31030500
[TBL] [Abstract][Full Text] [Related]
20. Effect of bacterial and host factors on Helicobacter pylori eradication therapy.
Uotani T; Miftahussurur M; Yamaoka Y
Expert Opin Ther Targets; 2015; 19(12):1637-50. PubMed ID: 26245678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
